Company intelligence / Profile preview

Totum Tech

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

Totum Tech has developed "Libero," an AI-powered wearable device designed to predict and prevent cold hand flare-ups associated with Raynaud’s disease. The product uses artificial intelligence to anticipate poor circulation events and automatically provide warmth, aiming to improve quality of life for people with cold sensitivity or invisible disabilities. The company is preparing its smart gloves for user testing, with a focus on personalized comfort solutions.

Therapeutic areas: CardiovascularNeurology
Modalities: DeviceDigital health solution (AI-powered wearable)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Totum Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Totum Tech.

Explore the full profile